Evommune, Inc. Deferred Offering Costs
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2025-12-11
- 2025-09-30: Deferred Offering Costs $2.10M.
| Period end | Deferred Offering Costs |
|---|---|
| 2025-09-30 | $2.10M 10-Q · filed 2025-12-11 |